October 1, 2025

President Trump's surprise drug pricing deal with Pfizer brings relief to the pharmaceutical industry, shielding them from crippling tariffs in exchange for billions in domestic investments. As drugmakers rush to strike similar agreements, Trump celebrates a major victory in his war on high drug costs - leaving consumers and critics to wonder if the true price of his triumph will be paid in the wallets of American patients.

Leave a Reply